Business Context and Reporting Period
This Form 8-K filing by OrthoPediatrics Corp. (KIDS) reports corporate governance changes effective August 8, 2025. The report date is August 7, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Resignation: Terry Schlotterback resigned from the Board of Directors effective August 8, 2025, due to retirement. The resignation was not the result of any disagreement with the Company.
- Director Appointment: Kelly Fischer was appointed to fill the vacancy caused by Mr. Schlotterback's departure. Her term expires at the 2026 annual stockholder meeting.
- Committee Assignments: Ms. Fischer has been appointed to the Audit Committee and Compensation Committee.
- Compensation Arrangement: Ms. Fischer will receive a pro rata portion of the 2025 Director Award. No other material plans or contracts were entered into.
- Equity Treatment: Mr. Schlotterback's remaining 10,900 unvested restricted stock shares will continue to vest on their original schedules despite his retirement.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the background and qualifications of new director Kelly Fischer, specifically her tenure as CFO at Cook Medical.
- Confirm the vesting schedule details for the 10,900 unvested shares retained by the retiring director.
- Review the Company's Non-Employee Director Compensation Policy (Exhibit 10.1 to the May 8, 2025 Form 10-Q) to understand the pro rata award calculation.
- Monitor future filings for any additional changes to the Board composition or committee structures.